Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
A pilot study published June 2021 in the Journal of Autism and Developmental Disorders demonstrated that BioStream’s digital therapeutic—combining applied behavior analysis with gaze-contingent eye tracking—improved emotion recognition in children with autism spectrum disorder. No large-scale clinical trial data or commercial launch reported.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioStream Technologies.